SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
GELFOND RICHARD L

(Last) (First) (Middle)
110 EAST 59TH STREET
SUITE 2100

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/14/2015
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
common shares (opening balance) 98,593 D
common shares (opening balance) 7,550 I by "Pamela Gelfond Trust"
common shares (opening balance) 7,550 I by "Claudia Gelfond Trust"
common shares 12/14/2015 C 33,333 (1) A $28.19 147,026 D
common shares 12/14/2015 S 33,333 (1) D $37.7637 113,693 D
common shares 12/15/2015 C 33,333 (1) A $28.19 147,026 D
common shares 12/15/2015 S 33,333 (1) D $39.0333 113,693 D
common shares 12/16/2015 C 33,334 (1) A $28.19 147,027 D
common shares 12/16/2015 S 33,334 (1) D $39.5755 113,693 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
stock options (to buy) $28.19 12/14/2015 C 33,333 (1) 05/01/2011 12/31/2020 common shares 33,333 $28.19 749,995 (2) D
stock options (to buy) $28.19 12/15/2015 C 33,333 (1) (3) 12/31/2020 common shares 33,333 $28.19 716,662 (2) D
stock options (to buy) $28.19 12/16/2015 C 33,334 (1) 09/01/2011 12/31/2020 common shares 33,334 $28.19 683,328 (2) D
Explanation of Responses:
1. Stock options were exercised and common shares sold pursuant to Rule 10b5-1 Sales Plan adopted on August 14, 2015. Mr. Gelfond's 10b5-1 Sales Plan is scheduled to terminate on September 16, 2016.
2. This represents the remaining balance of the options granted on the issue date, December 31, 2011, following this transaction. Mr. Gelfond's aggregate remaining outstanding option, RSU and long share balances following all transactions will be 1,577,648; 59,978 and 113,693 respectively.
3. The options became exercisable in 2 installments: 29,995 became exercisable on May 1, 2011 and 3,338 became exercisable on September 1, 2011.
Remarks:
Richard L. Gelfond 12/16/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.